drugset / Trial / NCT00702325
Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 160 ug | Inhaled |
| Comparator | Budesonide | Small molecule | 180 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 4.5 ug | Inhaled |